These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7784970)

  • 1. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
    Zakirova AN
    Ter Arkh; 1995; 67(4):33-5. PubMed ID: 7784970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia].
    Zakirova AN; Mingazetdinova LN; Kamilov FKh; Lankin VZ; Lebedev AV; Konovalova GG
    Ter Arkh; 1994; 66(9):24-8. PubMed ID: 7992206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of tactivin for treating patients with IHD].
    Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
    Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].
    Zakirova AN
    Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The neurohumoral and hemodynamic effect of aldizem in patients with stable and unstable angina pectoris].
    Malaia LT; Abidov AA; Kniaz'kova II
    Ter Arkh; 1993; 65(2):55-8. PubMed ID: 9133014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of emoxipin and neoton in unstable stenocardia].
    Golikov AP; Riabinin VA; Golikov PP; Davydov BV; Polumiskov VIu; Rudnev DV; Taranova ZV
    Ter Arkh; 1996; 68(1):31-3. PubMed ID: 8644026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of the use of pumpan preparation in the treatment of severe forms of angina pectoris].
    Parshina SS; Golovacheva TV; Afanas'eva TN; Panchenko OV; Baldina AA; Starostina NV; Lial'chenko IF; Egorova LP
    Ter Arkh; 2000; 72(9):36-41. PubMed ID: 11076414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 16. Extent of myocardial ischemia during coronary occlusion in single vessel disease. A comparison between patients with exercise-induced angina and patients with recurrent angina at rest.
    Figueras J; Missorici M; Gil CP; Cortadellas J; Angel J
    Int J Cardiol; 2008 Jul; 127(3):433-5. PubMed ID: 17761314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical, hemodynamic and hormonal-metabolic effects of the calcium-antagonist treatment of middle-aged and elderly patients with IHD at the polyclinic stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD; Dudarev MV
    Ter Arkh; 1996; 68(1):42-5. PubMed ID: 8644030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].
    Ardashev VN; Smirnov AV; Ryndin AA; Shcherbak IuA
    Voen Med Zh; 1994 Jul; (7):29-31, 79. PubMed ID: 7810109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic heart disease: dental management considerations.
    Hupp JR
    Dent Clin North Am; 2006 Oct; 50(4):483-91, v. PubMed ID: 17000269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.